Skip to content
Health & Beauty

When Antidepressants Don't Work, More Patients Are Trying TMS Therapy

For those patients, cycling through new prescriptions can eat up months, and each failed attempt tends to leave people feeling more discouraged than the last.

News Vortix EditorialEditorial desk
Published · 5 min read
When Antidepressants Don't Work, More Patients Are Trying TMS Therapy

For millions of people with depression, the standard playbook of talk therapy and antidepressant medication works well enough. But for a large minority, it doesn't, no matter how many prescriptions or providers they try. That gap has a clinical name, treatment-resistant depression, and it is pushing more patients and psychiatrists toward an option that looked experimental a decade ago and now looks increasingly mainstream.

When Medication Isn't Enough

Doctors generally use the term treatment-resistant depression to describe someone who has tried at least two different antidepressants, at adequate doses and for long enough, without meaningful relief. Estimates vary by study, but many clinicians put the number at roughly one in three people with major depression at some point in their illness. For those patients, cycling through new prescriptions can eat up months, and each failed attempt tends to leave people feeling more discouraged than the last.

That is the gap transcranial magnetic stimulation, or TMS, has stepped into. It isn't offered as a first option. Psychiatrists typically bring it up only after medication and psychotherapy haven't gotten a patient far enough, and after other explanations for a poor response, like an incorrect diagnosis or an untreated medical condition, have been ruled out.

treatment-resistant depression

How TMS Therapy Actually Works

TMS uses a magnetic coil placed against the scalp to send short pulses into a part of the brain called the dorsolateral prefrontal cortex, a region tied to mood regulation. According to the National Institute of Mental Health, the therapy is noninvasive and works by using an electromagnet to deliver repeated low-intensity pulses, producing a magnetic field roughly as strong as the one used in a standard MRI scan. A session usually runs 20 to 40 minutes. Patients stay awake and alert the whole time and can typically drive themselves home or head back to work right after.

The FDA cleared the first TMS device for depression in 2008, specifically for people who had not responded to medication. Since then, clearance has expanded to include obsessive-compulsive disorder, migraines, anxiety that occurs alongside depression, and smoking cessation, though the therapy is not approved for patients under 15. A typical course runs five days a week for four to six weeks, with sessions tapering off as symptoms start to lift.

As coverage has improved and more referring physicians grow comfortable with the therapy, practices built around mood disorders have gotten busier. Clinics like Village TMS in Manhattan now have more capacity than they did five years ago, and shorter waits for patients trying to get started.

What the Research Shows

The evidence base has grown well beyond the original FDA trials. Researchers funded by the National Institute of Mental Health have recently pushed the science further, testing whether TMS could reach brain structures that standard coils cannot stimulate directly. In one study out of the University of Pennsylvania's Center for Brain Imaging and Stimulation, patients who received a short course of the therapy saw their depression symptoms improve by roughly a third, alongside a similar drop in anxiety symptoms. Researchers linked the change to shifts in a deep brain region connected to mood regulation, offering a possible explanation for why TMS helps some patients who haven't responded to anything else.

tms therapy

Findings like that matter specifically because treatment-resistant depression by definition means the easier options have already failed. Every additional study gives psychiatrists more confidence recommending TMS, and gives patients who have spent years cycling through medications a reason to take a fresh look at it.

Side effects tend to be mild: scalp discomfort during the session, occasional headaches, and a small, closely monitored risk of seizure. Unlike electroconvulsive therapy, TMS does not require anesthesia and is not linked to memory loss, which is part of why it has drawn interest from patients who were wary of more intensive interventions.

Psychiatrists say the patients who tend to do best are the ones who come in with a clear diagnosis of major depression and a documented history of trying, and not fully responding to, standard antidepressants. That screening step matters, since TMS is built to address a specific kind of nonresponse rather than depression in general, and a thorough intake helps set realistic expectations before anyone starts a six-week course of daily sessions.

Weighing the Cost of Treatment

Cost has historically been the biggest barrier to access. A full course of TMS can run into the thousands of dollars without insurance, though coverage has improved substantially over the past several years. Most major insurers, including Medicare, now cover TMS for major depressive disorder once a patient has documented at least one or two antidepressant trials that didn't work, which lines up closely with the clinical definition of treatment-resistant depression.

depression treatment

Patients weighing the option are usually encouraged to call their insurer directly and ask a prospective provider to walk through the numbers before committing to a course of treatment, since plans differ widely on prior authorization and session limits. Clinics that publish a clear breakdown of what a course typically costs tend to make that first conversation easier for patients who are already stretched thin trying to get better.

What This Means for People Seeking Help

None of this makes TMS a cure-all, and clinicians are careful to say so. It works for a meaningful share of the patients who try it, not everyone, and it is usually one part of a broader treatment plan that still includes therapy and sometimes medication. Response rates also vary depending on how many prior treatments a patient has already tried, which is part of why psychiatrists say earlier referral, rather than waiting through several more medication trials, tends to produce better outcomes.

But for people who have spent years being told to just try another pill, the growing evidence behind TMS offers something that has been in short supply for a while: a genuine next step, not just more of the same.

Anyone who has tried two or more antidepressants without adequate relief generally fits the clinical picture for treatment-resistant depression, and is usually a reasonable candidate for a conversation with a psychiatrist about whether TMS makes sense, whether or not they ever end up sitting under the coil themselves.

This article is for general informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified health provider with questions about a medical condition.

#TMS therapy#antidepressants#depression#mental health#nyc#new york city
Written by
News Vortix Editorial
Editorial desk

Work produced and reviewed by the News Vortix editorial desk. Every piece published under this byline has been checked against our accuracy, sourcing and disclosure standards before going live. Corrections and enquiries are welcome and are handled by the desk directly.

View all posts by News

More in Health & Beauty

View all